An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria

Development of a globally effective HIV-1 vaccine will need to encompass Nigeria, one of the hardest hit areas, with an estimated 3.2 million people living with HIV. This cross-sectional Institutional Review Board (IRB) approved study was conducted in 2009–12 at four market sites and two highway set...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Njoku, Ogbonnaya S., Manak, Mark M., O’Connell, Robert J., Shutt, Ashley L. W., Malia, Jennifer A., Heipertz, Richard A., Tovanabutra, Sodsai, Milazzo, Mark J., Akintunde, Gideon Akindiran, Alabi, Abraham S., Suleiman, Aminu, Ogundeji, Amos A., Kene, Terfa S., Nelson, Robbie, Ayemoba, Ojor R., Singer, Darrell E., Robb, Merlin L., Peel, Sheila A., Michael, Nelson L.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5147844/
https://ncbi.nlm.nih.gov/pubmed/27936236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0166711
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars